Larimar Therapeutics, Inc. (LRMR)
NASDAQ: LRMR · IEX Real-Time Price · USD
7.71
-0.53 (-6.43%)
At close: Jul 2, 2024, 4:00 PM
8.09
+0.38 (4.93%)
After-hours: Jul 2, 2024, 7:26 PM EDT
Larimar Therapeutics Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for LRMR stock have an average target of 21.33, with a low estimate of 14 and a high estimate of 25. The average target predicts an increase of 176.65% from the current stock price of 7.71.
Analyst Consensus: Strong Buy
* Price targets were last updated on May 31, 2024.
Analyst Ratings
The average analyst rating for LRMR stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 1 | 1 |
Buy | 1 | 1 | 1 | 2 | 2 | 2 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 3 | 3 | 3 | 4 | 3 | 3 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
JMP Securities | JMP Securities | Buy Reiterates $25 | Buy | Reiterates | $25 | +224.25% | May 31, 2024 |
Citigroup | Citigroup | Strong Buy Maintains $10 → $14 | Strong Buy | Maintains | $10 → $14 | +81.58% | May 22, 2024 |
JMP Securities | JMP Securities | Buy Reiterates $25 | Buy | Reiterates | $25 | +224.25% | May 21, 2024 |
Leerink Partners | Leerink Partners | Buy Initiates $25 | Buy | Initiates | $25 | +224.25% | Apr 3, 2024 |
JMP Securities | JMP Securities | Buy Reiterates $25 | Buy | Reiterates | $25 | +224.25% | Mar 15, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.33
from -0.84
EPS Next Year
-2.02
from -1.33
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | n/a | n/a | 51.5M | 205.8M | 349.1M |
Avg | n/a | n/a | 37.0M | 101.7M | 223.8M |
Low | n/a | n/a | 15.9M | 4.5M | 119.5M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | 455.7% | 243.2% |
Avg | - | - | - | 174.7% | 120.0% |
Low | - | - | - | -87.7% | 17.4% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -1.26 | -1.34 | -1.33 | -3.59 | -3.06 |
Avg | -1.33 | -2.02 | -2.34 | -3.49 | -2.97 |
Low | -1.41 | -2.37 | -3.00 | -3.35 | -2.85 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | - | - |
Avg | - | - | - | - | - |
Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.